Singaporean startup FathomX scores almost $2M to hasten breast cancer AI development
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.
Source: mobihealthnews - Category: Information Technology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Information Technology | Singapore Health | Study